AKT1 and Alzheimer disease: In diabetes, AGEs activate the MEK/ERK, PI3K/Akt, and NF-κB pathways via RAGE, resulting in the upregulation of pro-inflammatory signals in an in vitro AD model using a microglial cell line8.